< Arab Finance - News - EIPICO sales reach EGP 1.5B in H1 2021
Count Down to relaunch



EIPICO sales reach EGP 1.5B in H1 2021

EIPICO sales reach EGP 1.5B in H1 2021

ArabFinance: The Egyptian International Pharmaceutical Industries Company (EIPICO) (PHAR) achieved sales in the first half (H1) of 2021 of EGP 1.54 billion, Ahmed Kilani said in a statement filed to the Egyptian Exchange.

The company’s exports reached $22.7 million in H1 2021, recording a 45% year on year increase, Kilani said, noting EIPICO acquires 23% of drug exports market share.

The drug company is expanding its exports to Latin American markets such as Venezuela

By expanding its exports to Latin American markets such as Venezuela, EIPICO has become exporting to 70 countries all over the world.

EIPICO announced earlier that it will acquire a land plot next to EIPICO 2 plant in 10th of Ramadan City.

The company’s consolidated net profit reached EGP 487.4 million in 2020.  

EIPICO is an Egypt-based public shareholding company that operates in the pharmaceutical industry. It is a manufacturer and exporter of pharmaceuticals and holds license agreements with a group of international.

#Related keywords

'

Recommended Stocks

04 Oct 2021
United Housing & Development UNIT
Close
04.19
Change
11.44
Buy

All rights reserved to Arab Finance 2020 ©

Back to top